News Archive
Filter by Division
Filter by Categories
Rogel Researchers Receive $4M Through Prostate Cancer Foundations Inaugural TACTICAL Awards Program
January 10, 2023 / MctpThe University of Michigan Rogel Cancer Center researchers received one of the Prostate Cancer Foundation’s four inaugural Class of 2022 TACTICAL (Therapy ACceleration To Intercept Cancer Lethality) Award. This $30 million program will support cross-disciplinary pioneering research toward the goal of developing 21st Century therapies for the most life-threatening form of prostate cancer [...]
Clear Cell Renal Cell Carcinoma study results published
January 6, 2023 / Experimental PathologyMembers of the University of Michigan Department of Pathology and Michigan Center for Translational Pathology, in collaboration with the Clinical Proteomic Tumor Analysis Consortium, recently published a large study on clear cell renal cell carcinomas (ccRCCs), which represent about 75% of the RCC cases and account for the most RCC-associated deaths. This study set out to create a comprehensive profile of ccRCC, combining histologic and molecular profiles. By analyzing both the microscopic cell structures and the genetic makeup of the cells, these researchers discovered significant intratumoral heterogeneity in 90% of ccRCCs. This indicates that ccRCCs originate from multiple tumor cell lines, called tumor subclones, that may become metastatic and could independently influence response to therapies. Through this study, the team was able to molecularly stratify aggressive histopathic subtypes, which may lead to more effective treatment strategies for patients and improved survival.
Cytomorphology and IHC helps diagnose transformed metastatic prostate cancer
October 27, 2022 / MctpA research team from the Michigan Center for Translational Pathology undertook a study to illustrate how careful assessment of cytologic and biomarker features may provide physicians with information on Metastatic Prostatic Cancer (MCP) patients’ prognosis and the best therapies to consider [...]
Researchers Find Link Between Genetic Mutations and Cancer Treatment Resistance
July 26, 2022 / MctpPatients with relapsed multiple myeloma are resistant to commonly used treatments. Researchers are one step closer to understanding the genetic reason why.
Using Artificial Intelligence to predict ERG Gene Fusion in Prostate Cancer
May 10, 2022 / Cancer ResearchThe role of artificial intelligence (AI) in healthcare continues to expand. In a recent issue of BMC Cancer, Dr. Vipulkumar Dadhania (first author) and colleagues published a result of their study Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer. The expert team from the Michigan Center for Translational Pathology developed a deep-learning-based model to predict ERG genomic rearrangements in prostatic adenocarcinomas using only H&E-stained digital slides [...]
Arul Chinnaiyan, MD, PhD, selected for the Sjöberg Prize in Cancer Research
February 11, 2022 / MctpThe Royal Swedish Academy of Sciences, which also awards the Nobel Prizes, announced today that Arul Chinnaiyan, MD, PhD, S.P. Hicks Professor of Pathology and Urology at Michigan Medicine and Director of the Michigan Center for Translational Pathology, has been selected as [...]
Study Demonstrates a Novel Approach to Target Enhancer-Addicted Cancers
January 4, 2022 / MctpA chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.
Inside the COVID Pandemic: A Laboratory Perspective
November 29, 2021 / InsidepathThe SARS-CoV-2 virus brought lab testing to the headlines. Learn how Michigan Medicine Pathology responded to this unprecedented challenge.
TRIM63 - What is it? (Hint: Not a weight-loss product)
August 9, 2021 / CancerDr. Xiao-Ming (Mindy) Wang and colleagues from the Michigan Center for Translational Pathology and Department of Pathology published a groundbreaking finding from an inter-institutional study regarding TRIM63 in Modern Pathology [...]
Researchers Uncover Way to Harness the Power of Immunotherapy for Advanced Prostate Cancer
August 3, 2021 / BlogFindings offer clues to why some types of renal cell carcinoma respond to immunotherapy while others do not — it’s a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy?
Analysis Reveals How Kidney Cancer Develops and Responds to Treatment
June 10, 2021 / MctpNot all kidney cancers behave the same, with wildly different responses to immunotherapy or other treatments – and wildly different outcomes for patients as a result. By sequencing the RNA of individual cells within multiple benign and cancerous kidney tumors, researchers from the University of Michigan Rogel Cancer Center have identified the cells [...]
Study Suggests Path to Blocking Common Genetic Driver of Lung Cancer
May 12, 2021 / MctpStopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models.
Arul Chinnaiyan, MD, PhD, Recognized for Outstanding Research
May 7, 2021 / AwardCongratulations to Arul Chinnaiyan, MD, PhD, who was announced as the Science of Oncology Award and Lecture recipient by the American Society of Clinical Oncology (ASCO). As part of this award, Chinnaiyan will present a 30-minute lecture entitled “Exploring Precision Oncology: from Gene Fusions to Related Genetic Drivers“ at the ASCO Annual Meeting, to be held virtually on June 4-8, 2021 [...]
Arul Chinnaiyan, MD, PhD Recognized for Outstanding Research
May 3, 2021 / MctpCongratulations to Arul Chinnaiyan, MD, PhD, who was announced as the Science of Oncology Award and Lecture recipient by the American Society of Clinical Oncology (ASCO). As part of this award, Chinnaiyan will present a 30-minute lecture entitled “ “ at the ASCO Annual Meeting, to be held virtually on June 4-8, 2021.
Biomarker Could Help Identify Difficult-to-Diagnose Kidney Cancer Subtype
April 14, 2021 / Cancer ResearchMiTF renal cell carcinoma can masquerade as other subtypes and may not respond as well to front-line therapies.
New Assay For Early Detection of Aggressive Prostate Cancers Developed
April 13, 2021 / Cancer ResearchA new study, led by U-M graduate in molecular and cellular pathology Dr. Andi Cani, was just published in European Urology Oncology. The publication focuses on the development of a whole-urine, multiplexed, next-generation RNA-sequencing assay that is used for the early detection of aggressive forms of prostate cancer [...]
"A Correct Diagnosis Can Be Life-Changing": Dr. Rohit Mehra
March 9, 2021 / Careers In PathologyDr. Mehra discusses his career path and how he arrived at Michigan Medicine in our latest Careers in Pathology video.
Stressed Cellular Protein HOPS Into Action
February 16, 2021 / Experimental PathologyResearch team discovered that proteins with the capacity to multimerize quickly responded to osmotic changes (dehydration) caused by high saline or sugar concentrations, condensing into aggregates resembling processing bodies (P-bodies). The reaction, known as hyperosmotic phase separation, or HOPS, takes only a few seconds and is reversible within less than 2 minutes [...]
Research from Dr. Udager Published in European Urology
February 1, 2021 / CancerA new publication, generated by Department of Pathology faculty members Drs. Aaron Udager and Scott Tomlins was successfully published in European Urology. The research highlights a longitudinal cohort study centered around the serial molecular profiling of low-grade prostate cancer in order to better assess tumor upgrading [...]
Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead
December 22, 2020 / Cancer ResearchClinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus. wo proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, MD, PhD. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers [...]
Research Regarding Microcystic Adnexal Carcinomas Published
June 11, 2020 / Cancer ResearchThe research was just published in Modern Pathology and highlights the importance of next-generation sequencing within oncogenic roles for P53 and JAK/STAT signaling in microcystic adnexal carcinomas.
U-M Researchers Home in on Key Player in Pancreatic Cancer Development
June 4, 2020 / MctpThe protein Argonaute 2 was found to be critical to the progression from benign lesions into pancreatic cancer, suggesting a therapeutic opportunity.
Research Regarding Invasive Squamous Cell Carcinoma Published
May 29, 2020 / Experimental PathologyThe research, which focuses on invasive squamous cell carcinomas and the precursor lesions that demonstrate concordic genomic complexity in driver genes, was just published in Modern Pathology.
Research about Renal Cell Carcinoma in Young Adults Published
May 22, 2020 / PublicationsThe research was just published in Histopathology and features prominent contributions from our faculty.
Arul Chinnaiyan, MD, PhD, elected to the National Academy of Science
April 28, 2020 / AwardCongratulations to Arul M. Chinnaiyan, MD, PhD, on his election to the National Academy of Science! Chinnaiyan is an investigator, Howard Hughes Medical Institute; and S.P. Hicks Endowed Professor of Pathology, American Cancer Society Research Professor, and director, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor [...]
Marcin Cieslik Receives Award from Bristol-Myers Squibb
March 11, 2020 / AwardMarcin Cieslik, Assistant Professor of Pathology and Computational Medicine and Bioinformatics and member of the Michigan Center for Translational Pathology (MCTP), received an award from Bristol-Myers Squibb (BMS) for the project entitled, “Identification of novel therapeutic vulnerabilities across immunophenotypes of refractory and metastatic tumors.” This award provides two years of funding.
Engaging Our Future
November 8, 2019 / OutreachDepartment faculty outreach to high school students to educate about careers in medicine and research.
Faculty and Trainees Work to Understand Therapy-Resistant Malignancies
October 30, 2019 / FacultyTwo Michigan Medicine Fellows, Caroline Simon, MD, and Stephanie Skala, MD, (who recently joined the Department of Pathology as faculty), joined colleagues from the Michigan Center for Translational Pathology, in a research study published in Diagnostic Pathology dated October 21, 2019 [...]
U-M Compounds Show Promise in a Lab Model of Advanced Prostate Cancer
May 14, 2019 / Experimental PathologyA new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.
Witnessing the dance of RNAs around droplets of cellular degradation machinery
April 3, 2019 / Experimental PathologyIf a picture's worth a thousand words, a video is perhaps worth much more.
Medicine, Humility, Respect, and Beyond
November 8, 2018 / NewsletterRohit Mehra, MD—faculty perspective on the need to understand why a patient’s cancer would not respond to treatment.
Team Led by Dr. Rohit Mehra discovers New Diagnostic Biomarker for Kidney Cancer
October 11, 2018 / Experimental PathologyA recent collaborative study out of the Michigan Center for Translational Pathology (MCTP) has led to new insight into kidney cancer. The resulting paper, VSTM2A Overexpression is a Sensitive and Specific Biomarker for [...]
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
